UK markets open in 6 hours 38 minutes
NIKKEI 225
39,567.37 -63.69 (-0.16%) HANG SENG
17,718.61 +2.11 (+0.01%) CRUDE OIL
83.49 +0.11 (+0.13%) GOLD FUTURES
2,343.00 +4.10 (+0.18%) DOW
39,169.52 +50.66 (+0.13%) Bitcoin GBP
49,634.47 +137.56 (+0.28%)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
At close: 03:00PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 53.72B |
| Enterprise value | 73.60B |
| Trailing P/E | 29.51 |
| Forward P/E | 17.76 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.46 |
| Price/book (mrq) | 1.28 |
| Enterprise value/revenue | 1.81 |
| Enterprise value/EBITDA | 17.17 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | -28.67% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 32.08 |
| 52-week low 3 | 20.38 |
| 50-day moving average 3 | 23.31 |
| 200-day moving average 3 | 25.11 |
Share statistics
| Avg vol (3-month) 3 | 8.86M |
| Avg vol (10-day) 3 | 7.86M |
| Shares outstanding 5 | 2.12B |
| Implied shares outstanding 6 | 2.4B |
| Float 8 | 1.7B |
| % held by insiders 1 | 42.37% |
| % held by institutions 1 | 6.75% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.42 |
| Forward annual dividend yield 4 | 1.90% |
| Trailing annual dividend rate 3 | 0.27 |
| Trailing annual dividend yield 3 | 1.22% |
| 5-year average dividend yield 4 | 1.16 |
| Payout ratio 4 | 56.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 09 Aug 2023 |
| Last split factor 2 | 1.5:1 |
| Last split date 3 | 26 Jul 2010 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 4.94% |
| Operating margin (ttm) | 9.65% |
Management effectiveness
| Return on assets (ttm) | 0.61% |
| Return on equity (ttm) | 4.56% |
Income statement
| Revenue (ttm) | 40.69B |
| Revenue per share (ttm) | 15.26 |
| Quarterly revenue growth (yoy) | -6.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 3.87B |
| Net income avi to common (ttm) | 2.01B |
| Diluted EPS (ttm) | 0.75 |
| Quarterly earnings growth (yoy) | -38.20% |
Balance sheet
| Total cash (mrq) | 15.02B |
| Total cash per share (mrq) | 5.62 |
| Total debt (mrq) | 34.9B |
| Total debt/equity (mrq) | 60.66% |
| Current ratio (mrq) | 1.01 |
| Book value per share (mrq) | 17.34 |
Cash flow statement
| Operating cash flow (ttm) | 3.46B |
| Levered free cash flow (ttm) | -2.51B |
© 2024 Yahoo. All rights reserved.